OpportunityTitle: Early HIV Treatment to Optimize Patient Health and HIV Prevention
AdditionalInformationOnEligibility: Additional Information on Eligibility Applicant organizations that request funding above the ceiling amount of the award will not be forwarded to peer review or considered for funding.
Description: The purpose of this project is to evaluate the feasibility of initiating antiretroviral therapy (ART) in persons diagnosed with acute or early HIV infection. We propose a prospective study of innovative approaches for initiating ART in persons diagnosed with acute or early HIV infection within days of their diagnosis. The primary outcomes of interest will be time to viral suppression and the proportion of patients who remain virally suppressed 12 months after diagnosis. Additional outcomes may include retention in HIV care, patient satisfaction with clinical care, changes in HIV transmission risk behavior, an evaluation of laboratory markers of viral suppression, and other outcomes as determined by patient input and the study investigators.
GrantorContactEmailDescription: Grants Policy
GrantorContactText: Paul Smutz&lt;br/&gt;POS1@cdc.gov&lt;br/&gt;
CloseDateExplanation: Electronically submitted applications must be submitted no later than 5:00 p.m., ET, on the listed application due date.